Diagnostics, Cataracts, Practice Management


Pre-owned equipment, practices for sale, open positions, helpful practice management resources and more!

Click here to view the latest classifieds from Ophthalmology Management.

Welcome to AMD Update!

It is estimated that 15 million people in the United States have age-related macular degeneration (AMD), with more than 1.75 million having advanced disease (defined as neovascular AMD or geographic atrophy); the number with advanced disease is expected to climb to almost 3 million by the year 2020. AMD is the leading cause of blindness in adults over 55 years of age.

AMD Update is a monthly e-newsletter dedicated to bringing to the ophthalmologist the latest and most useful clinical information and literature reviews on the management of AMD in a quick, easy to review format. The articles are written by a variety of authors in order to draw upon a wealth of expertise.

We hope that you will find the information timely and applicable to your practice, and that you will look forward to each issue.

Ingrid U. Scott, MD, MPH, Editor

We are pleased to have Ingrid U. Scott, MD, MPH as Editor of AMD Update.

Ingrid U. Scott, MD, MPH, is Professor of Ophthalmology and Public Health Sciences at Penn State College of Medicine. She earned her Medical Degree (MD) and Master's in Public Health (MPH) Degree from Johns Hopkins University, and completed an ophthalmology residency, a fellowship in vitreoretinal surgery and diseases, and chief residency at Bascom Palmer Eye Institute, University of Miami.

She served as Vice-Chair of the Diabetic Retinopathy Clinical Research (DRCR) Network funded by the National Eye Institute (NEI), Co-Chair of the NEI-funded Standard Care versus Corticosteroid for Retinal Vein Occlusion (SCORE) Study, and Executive Committee member of the NEI-funded Age-Related Eye Disease 2 (AREDS2) Study. Dr. Scott serves as Chair of the NEI-funded Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2 Study). She lectures widely in national and international forums, and has authored/co-authored over 300 peer-reviewed publications and over 40 book chapters/monographs. Dr. Scott served as Associate Editor of JAMA Ophthalmology and serves on the editorial board of numerous ophthalmology journals. She served as Chair and Methodologist of the Ophthalmic Technology Assessment Committee Retina Panel of the American Academy of Ophthalmology (AAO) and as a member of the AAO's Preferred Practice Patterns Retina Panel.

Dr. Scott has received the American Medical Association's Physician's Recognition Award every year since 2003, the American Medical Association's Physician's Recognition Award with Commendation every year since 2010, the AAO's Senior Achievement Award, and has been named to the Best Doctors in America every year since 2003. As part of the American Medical Association's Physician Mentor Recognition Program, Dr. Scott was recognized as "a physician mentor who has made a significant difference in the professional lives of other physicians, and who serves as an influential role model for other physicians."

Archived Newsletters

Issue 82 - Gene Therapy for Exudative AMD: AAV2-sFLT-1
Issue 81 - Investigating Cell Therapy for Advanced Atrophic Macular Degeneration
Issue 80 - Switching Treatment from One Anti-VEGF Agent to Another: Does It Improve Outcomes in Patients with Neovascular AMD?
Issue 79 - Genetic Testing in Age-Related Macular Degeneration and AREDS Supplement Use
Issue 78 - Squalamine Eye Drops for Retinal Disease
Issue 77 - Complement Inhibition as a Potential Treatment for Geographic Atrophy
Issue 76 - Gene Therapy: The Next Frontier in Managing Exudative AMD
Issue 75 - Sustained Release Anti-Vascular Endothelial Growth Factor Therapies for Neovascular Age-Related Macular Degeneration
Issue 74 - Treat and Extend Management of Neovascular AMD: What Data Do We Have?
Issue 73 - Laser Photocoagulation: Is There Still a Use for This Treatment Modality in Exudative AMD?
Issue 72 - The Role of Topical Antibiotics for Intravitreal Injections
Issue 71 - Retinal Angiomatous Proliferation
Issue 70 - Enhanced Depth Imaging of Spectral Domain Optical Coherence Tomography in Age-Related Macular Degeneration
Issue 69 - Update on Treatment for Neovascular Age-Related Macular Degeneration
Issue 68 - Evolving Drug Delivery Techniques for Treating AMD
Issue 67 - Global Burden of Disease Study: Prevalence and Causes of Blindness and Visual Impairment
Issue 66 - Treatment of Exudative AMD That Responds Poorly to Initial Anti-VEGF Therapy
Issue 65 - Pigment Epithelial Detachments and Age Related Macular Degeneration
Issue 64 - A Glimpse into Epigenetic Regulation of Age-Related Macular Degeneration
Issue 63 - Microperimetry and Retinal Sensitivity in the Management of Age-Related Macular Degeneration
Issue 62 - Compounding Pharmacies: Recent Outbreaks of Infection and Implications for the Care of Patients with Age-Related Macular Degeneration
Issue 61 - Management of Submacular Hemorrhage Associated with Neovascular Age-Related Macular Degeneration
Issue 60 - Why Do Anti-VEGF Agents Not Work in All Patients with Neovascular AMD?
Issue 59 - Genetic Testing for AMD
Issue 58 - Emerging Practice Patterns with Aflibercept for the Treatment of Exudative Age-Related Macular Degeneration
Issue 57 - Nonsteroidal Anti-inflammatory Drugs for Age-Related Macular Degeneration
Issue 56 - Is IOP Measurement Immediately After Intravitreal Injection of Anti-VEGF Therapy Necessary?
Issue 55 - The Role of C-Reactive Protein as a Biomarker in Age-Related Macular Degeneration
Issue 54 - Investigational Therapies for Dry AMD
Issue 53 - Platelet Derived Growth Factor (PDGF) Antagonism in Neovascular Age-Related Macular Degeneration
Issue 52 - Monotherapy Treatment Strategies for Neovascular AMD
Issue 51 - A Comparison of Local Anesthesia Techniques for Intravitreal Injections
Issue 50 - The Clinical Course of Adult "Vitelliform" Macular Lesions
Issue 49 - Genetics of AMD
Issue 48 - Bullous Retinal Pigment Epithelial Detachment:Two Different Stories
Issue 47 - Novel Radiation Technique for the Treatment of Neovascular Age-Related Macular Degeneration
Issue 46 - Submacular Hemorrhage Associated with Age-Related Macular Degeneration: Favorable Response to Treatment With Intravitreal Ranibizumab Alone
Issue 45 - Distinguishing Age-related Macular Degeneration from Other Macular Conditions
Issue 44 - The Role of Inflammation in the Pathogenesis of Age-Related Macular Degeneration
Issue 43 - Combination Treatment with Epimacular Brachytherapy and Anti-VEGF Therapy for Age-Related Macular Degeneration
Issue 42 - The "Treat and Extend" Dosing Regimen of Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
Issue 41 - Comparison of Two Doses of Intravitreal Bevacizumab as Primary Treatment for Subfoveal CNV Associated with AMD at 24 Months: The Pan-American Collaborative Retina Study Group
Issue 40 - Vitreoretinal Adhesion and Age-Related Macular Degeneration
Issue 39 - Cataract Surgery for Patients with Advanced Age-Related Macular Degeneration
Issue 38 - Spectral-Domain Optical Coherence Tomography: Comparing Commercially Available Systems for Managing Patients with Age-Related Macular Degeneration
Issue 37 - Implantable Miniature Telescope for End-Stage Age-Related Macular Degeneration
Issue 36 - Management of Subretinal Hemorrhage
Issue 35 - Managing the Patient with Bilateral Wet Macular Degeneration
Issue 34 - Genetics of Age-Related Macular Degeneration
Issue 33 - Ciliary Neurotrophic Factor in the Treatment of Advanced Nonexudative Age-Related Macular Degeneration
Issue 32 - The Role of Vitamin A in the Progression of Dry AMD
Issue 31 - VEGF-Trap Eye: What's the Evidence?
Issue 30 - Vision-Related Function in Patients with Age-Related Macular Degeneration
Issue 29 - Fluorescein Angiography in Age-Related Macular Degeneration
Issue 28 - Age-Related Macular Degeneration and Cardiovascular Disease
Issue 27 - Optical Coherence Tomography in Age-Related Macular Degeneration (AMD)
Issue 26 - The Use of Autofluorescence Imaging in AMD
Issue 25 - Triple Therapy for the Treatment of CNV Due to AMD
Issue 24 - AMD Research: Current Needs and Future Directions
Issue 23 - Omega-3 Fatty Acid-Derived Resolvins and Protectins in Age-Related Macular Degeneration
Issue 22 - Neovascular AMD: Not Only VEGF
Issue 21 - A Combination of Anti-VEGF Therapy and Epi-retinal Radiation for the Treatment of Neovascular Age-related Macular Degeneration
Issue 20 - Cataract Surgery in the Patient with AMD
Issue 19 - Cell-based Therapies for AMD - a Cure on the Horizon?
Issue 18 - The Complex Role of Innate Immunity in Ocular Angiogenesis
Issue 17 - The Hidden Cost of Avastin AMD Therapy?
Issue 16 - Triple Therapy in Exudative AMD
Issue 15 - New OCT Devices: Implications for AMD Management
Issue 14 - Intravitreal Anti-VEGF Plus PDT Combination Therapy for Neovascular AMD: A Clinical Perspective
Issue 13 - Risk in AMD: Insight from Studies on Environmental Risk Factors, Genotype, and VEGF
Issue 12 - Value-Based Medicine and Interventions for Neovascular Age-Related Macular Degeneration
Issue 11 - The Role of Photodynamic Therapy in AMD Management
Issue 10 - Artificial Vision
Issue 09 - How Long Should we Treat Patients with Anti-VEGF Therapy for Wet AMD Once the Lesion is Dry?
Issue 08 - The Role of Fluorescein Angiography in AMD Management
Issue 07 - Effect of Early Detection of Neovascular AMD on Visual Outcome
Issue 06 - Monitoring for the Conversion of Dry to Wet Age-Related Macular Degeneration
Issue 05 - Should Lutein and Other Nutritional Supplements Be Given for the Therapy of Age-Related Macular Degeneration?
Issue 04 - Is There a Place for Combination Therapy in Neovascular AMD?
Issue 03 - Follow-up of AMD Patients Treated with Anti-VEGF Therapy: How to Monitor and Decide on Retreatment
Issue 02 - The Role of Intravitreal Triamcinolone Acetonide in AMD Management
Issue 01 - Lucentis and Avastin: When to Use Which?